首页> 外国专利> A VACCINE FOR COMBATTING PLEUROPNEUMONIA IN PIGS, AND A PROCESS AND A SUBSTRATE FOR THE AEROBIC FERMENTATION OF HAEMOPHILUS PLEUROPNEUMONIAE

A VACCINE FOR COMBATTING PLEUROPNEUMONIA IN PIGS, AND A PROCESS AND A SUBSTRATE FOR THE AEROBIC FERMENTATION OF HAEMOPHILUS PLEUROPNEUMONIAE

机译:用于对抗猪肺炎肺炎的疫苗,以及嗜氧性肺炎嗜血杆菌肺炎需氧发酵的过程和基质

摘要

In an improved method of combating against pleuropneumonia pig by inoculation of a vaccine comprising cells of the known microorganism and generally available Haemophilus pleuropneumoniae, parts of such cells, extracts and / or metabolism of the product thereof as active substances, adjuvants, and a buffer, the improvement resulting from the use of a Bordetella pertussis vaccine, a biomass and / or extracts thereof as an adjuvant, concurrently with the new H. pleuropneumoniae vaccine comprising an adjuvant based on B, pertussis. The method and an improved vaccine LEAD protection of pigs against pleuropneumonia attacks without side effects. Moreover is described a new substrate and improves substrate referred to as "CAY" for the cultivation of microorganisms, particularly the bacteria H. pleuropneumoniae, which compared to the known substrates, results in a substantially higher yield of appropriate biomass for the production of H. pleuropneumoniae vaccine, this substrate comprising casaminique acid, yeast extract, glucose and adenine dinucleotide-nicotinamide (NAD) as essential ingredients and it lends itself to the culture of H. pleuropneumoniae in solid medium as well as in liquid medium by small changes in the composition of the substrate. An improved process for the aerobic fermentation of H. pleuropneumoniae in a liquid medium comprising the substrate "CAY", this fermentation being advantageously effected at a temperature of about 37 C, a pH of about 7.1 to 7.4 and has a oxygen concentration in the fermentation medium of about 8 to 12 ppm, and maintaining the oxygen concentration in Desired by varying the stirring speed and / or air flow.
机译:在一种改进的抗猪胸膜肺炎的方法中,通过接种一种疫苗,该疫苗包括已知微生物的细胞和通常可得的胸膜肺炎嗜血杆菌,这些细胞的一部分,其提取物和/或代谢产物的活性物质,佐剂和缓冲剂,由于使用百日咳博德特氏杆菌疫苗,生物量和/或其提取物作为佐剂,同时还包含基于百日咳杆菌B的佐剂的新型胸膜肺炎双球菌疫苗而产生的改善。该方法和改进的疫苗LEAD保护猪免受胸膜肺炎的侵袭而无副作用。此外,描述了一种新的底物,并改进了用于培养微生物特别是细菌胸膜肺炎链球菌的“ CAY”底物,与已知的底物相比,该底物可大大提高用于生产H的合适生物质的产率。胸膜肺炎疫苗,这种底物包含卡萨米尼克酸,酵母提取物,葡萄糖和腺嘌呤二核苷酸-烟酰胺(NAD)作为基本成分,可通过微小的成分变化使其在固体培养基和液体培养基中培养胸膜肺炎支原体基板的在包含底物“ CAY”的液体培养基中对胸膜肺炎支原体进行有氧发酵的改进方法,该发酵有利地在约37℃的温度,约7.1至7.4的pH下进行并且在发酵中具有氧浓度约8至12 ppm的介质,并通过改变搅拌速度和/或空气流量来保持所需的氧气浓度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号